Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phototherapy | 7 | 2021 | 28 | 0.970 |
Why?
|
| Bilirubin | 8 | 2021 | 51 | 0.790 |
Why?
|
| Infant, Newborn | 27 | 2022 | 2453 | 0.770 |
Why?
|
| Weight Loss | 7 | 2017 | 319 | 0.710 |
Why?
|
| Breast Feeding | 5 | 2017 | 159 | 0.600 |
Why?
|
| Birth Weight | 9 | 2017 | 186 | 0.550 |
Why?
|
| Nomograms | 4 | 2016 | 19 | 0.550 |
Why?
|
| California | 16 | 2018 | 99 | 0.540 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2018 | 12 | 0.540 |
Why?
|
| Infant, Premature | 9 | 2017 | 284 | 0.450 |
Why?
|
| Asthma | 5 | 2018 | 345 | 0.440 |
Why?
|
| Hyperbilirubinemia, Neonatal | 3 | 2016 | 6 | 0.430 |
Why?
|
| Sepsis | 3 | 2022 | 233 | 0.380 |
Why?
|
| Cesarean Section | 4 | 2018 | 101 | 0.360 |
Why?
|
| Postpartum Hemorrhage | 3 | 2019 | 12 | 0.350 |
Why?
|
| Neonatal Sepsis | 2 | 2020 | 3 | 0.340 |
Why?
|
| Hyperbilirubinemia | 3 | 2018 | 12 | 0.330 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2022 | 154 | 0.320 |
Why?
|
| Immunization | 2 | 2018 | 86 | 0.300 |
Why?
|
| Blood Culture | 3 | 2022 | 15 | 0.280 |
Why?
|
| Retrospective Studies | 18 | 2022 | 7264 | 0.280 |
Why?
|
| Anti-Bacterial Agents | 6 | 2022 | 1026 | 0.270 |
Why?
|
| Cohort Studies | 11 | 2021 | 2356 | 0.250 |
Why?
|
| Infant, Premature, Diseases | 3 | 2013 | 85 | 0.240 |
Why?
|
| Cerebral Palsy | 3 | 2015 | 24 | 0.240 |
Why?
|
| Female | 31 | 2022 | 38015 | 0.240 |
Why?
|
| Neonatal Screening | 2 | 2021 | 43 | 0.240 |
Why?
|
| Jaundice, Neonatal | 3 | 2016 | 8 | 0.220 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2022 | 27 | 0.210 |
Why?
|
| Delivery, Obstetric | 3 | 2016 | 58 | 0.210 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2021 | 2 | 0.210 |
Why?
|
| Risk Factors | 13 | 2018 | 5719 | 0.210 |
Why?
|
| Risk Assessment | 6 | 2019 | 2004 | 0.210 |
Why?
|
| Blood Cell Count | 1 | 2021 | 35 | 0.210 |
Why?
|
| Humans | 37 | 2022 | 68525 | 0.200 |
Why?
|
| Hospitalization | 2 | 2018 | 977 | 0.200 |
Why?
|
| Male | 26 | 2021 | 37281 | 0.200 |
Why?
|
| Antigens, CD34 | 1 | 2021 | 75 | 0.200 |
Why?
|
| Infant | 8 | 2022 | 2891 | 0.190 |
Why?
|
| Aftercare | 1 | 2021 | 114 | 0.190 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 62 | 0.180 |
Why?
|
| Bacteremia | 1 | 2022 | 155 | 0.180 |
Why?
|
| Leukapheresis | 1 | 2019 | 8 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 268 | 0.170 |
Why?
|
| Obstetric Labor Complications | 1 | 2019 | 20 | 0.170 |
Why?
|
| Puerperal Disorders | 1 | 2019 | 20 | 0.170 |
Why?
|
| Bacteria | 1 | 2020 | 193 | 0.170 |
Why?
|
| Pregnancy | 7 | 2022 | 2331 | 0.170 |
Why?
|
| Bronchiolitis, Viral | 1 | 2018 | 1 | 0.170 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2018 | 9 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2019 | 122 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 124 | 0.160 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 85 | 0.160 |
Why?
|
| Incidence | 6 | 2016 | 1582 | 0.150 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 42 | 0.150 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2016 | 15 | 0.150 |
Why?
|
| Gestational Age | 5 | 2020 | 389 | 0.150 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2016 | 11 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2016 | 120 | 0.140 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2015 | 8 | 0.140 |
Why?
|
| Anemia | 1 | 2016 | 104 | 0.130 |
Why?
|
| Maternal Exposure | 1 | 2016 | 75 | 0.130 |
Why?
|
| Kernicterus | 1 | 2015 | 7 | 0.130 |
Why?
|
| Bottle Feeding | 1 | 2015 | 20 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2019 | 374 | 0.130 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 3256 | 0.130 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 111 | 0.130 |
Why?
|
| Child, Preschool | 6 | 2018 | 3185 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2015 | 110 | 0.120 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 26 | 0.120 |
Why?
|
| Respiratory Sounds | 1 | 2013 | 35 | 0.120 |
Why?
|
| Bronchiolitis | 1 | 2013 | 3 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 467 | 0.110 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2013 | 72 | 0.110 |
Why?
|
| Proportional Hazards Models | 4 | 2016 | 791 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 191 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 529 | 0.100 |
Why?
|
| Time Factors | 5 | 2020 | 4655 | 0.100 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 1046 | 0.100 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 1465 | 0.090 |
Why?
|
| Child | 5 | 2018 | 6400 | 0.080 |
Why?
|
| Adult | 8 | 2021 | 21375 | 0.080 |
Why?
|
| Maternal Age | 2 | 2018 | 70 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2021 | 294 | 0.080 |
Why?
|
| Logistic Models | 3 | 2016 | 1419 | 0.070 |
Why?
|
| Models, Theoretical | 2 | 2021 | 384 | 0.070 |
Why?
|
| Exchange Transfusion, Whole Blood | 2 | 2015 | 13 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 1753 | 0.070 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 286 | 0.070 |
Why?
|
| Neoplasms | 1 | 2016 | 1660 | 0.060 |
Why?
|
| Young Adult | 3 | 2021 | 5708 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2015 | 1548 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2016 | 880 | 0.050 |
Why?
|
| Coagulase | 1 | 2022 | 14 | 0.050 |
Why?
|
| Staphylococcus | 1 | 2022 | 29 | 0.050 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2003 | 92 | 0.050 |
Why?
|
| Erythrocyte Indices | 1 | 2021 | 9 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2021 | 105 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2021 | 29 | 0.050 |
Why?
|
| Blood Component Removal | 1 | 2021 | 19 | 0.050 |
Why?
|
| Mothers | 1 | 2022 | 172 | 0.050 |
Why?
|
| Cell Count | 1 | 2021 | 248 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1851 | 0.050 |
Why?
|
| Age Factors | 2 | 2015 | 1860 | 0.050 |
Why?
|
| Prognosis | 2 | 2016 | 2093 | 0.050 |
Why?
|
| Forecasting | 1 | 2021 | 277 | 0.050 |
Why?
|
| Maternal Death | 1 | 2019 | 1 | 0.040 |
Why?
|
| Cardiotocography | 1 | 2019 | 3 | 0.040 |
Why?
|
| Uterine Rupture | 1 | 2019 | 4 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 195 | 0.040 |
Why?
|
| Uterine Hemorrhage | 1 | 2019 | 16 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2019 | 94 | 0.040 |
Why?
|
| Eclampsia | 1 | 2019 | 16 | 0.040 |
Why?
|
| Fetal Death | 1 | 2019 | 49 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 45 | 0.040 |
Why?
|
| Embolism | 1 | 2019 | 45 | 0.040 |
Why?
|
| Obstetrics | 1 | 2019 | 44 | 0.040 |
Why?
|
| Cytokines | 1 | 2003 | 866 | 0.040 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2019 | 56 | 0.040 |
Why?
|
| Parity | 1 | 2018 | 71 | 0.040 |
Why?
|
| Blood Coagulation Disorders | 1 | 2018 | 45 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2018 | 64 | 0.040 |
Why?
|
| Seasons | 1 | 2018 | 129 | 0.040 |
Why?
|
| Critical Illness | 1 | 2019 | 191 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 498 | 0.040 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2018 | 77 | 0.040 |
Why?
|
| Paternal Age | 1 | 2016 | 1 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 1593 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 737 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 202 | 0.040 |
Why?
|
| Spectrophotometry | 1 | 2016 | 54 | 0.040 |
Why?
|
| Tennessee | 1 | 2016 | 11 | 0.040 |
Why?
|
| Calibration | 1 | 2016 | 73 | 0.040 |
Why?
|
| Reference Standards | 1 | 2016 | 115 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2018 | 211 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 116 | 0.030 |
Why?
|
| Siblings | 1 | 2016 | 34 | 0.030 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2264 | 0.030 |
Why?
|
| Educational Status | 1 | 2016 | 273 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 71 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 219 | 0.030 |
Why?
|
| Infant Formula | 1 | 2015 | 24 | 0.030 |
Why?
|
| Microbiota | 1 | 2016 | 79 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2015 | 112 | 0.030 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2014 | 10 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 7028 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 14842 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2013 | 25 | 0.030 |
Why?
|
| Medicaid | 1 | 2016 | 301 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2016 | 267 | 0.030 |
Why?
|
| Age of Onset | 1 | 2013 | 188 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2013 | 44 | 0.030 |
Why?
|
| United States | 2 | 2016 | 7335 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 780 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 1265 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1745 | 0.030 |
Why?
|
| Middle Aged | 2 | 2021 | 21119 | 0.030 |
Why?
|
| Risk | 1 | 2013 | 563 | 0.030 |
Why?
|
| Body Weight | 1 | 2013 | 554 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 772 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 948 | 0.020 |
Why?
|
| Obesity | 1 | 2018 | 1074 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4843 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1609 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2077 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 8903 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1194 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2222 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2003 | 73 | 0.010 |
Why?
|
| Skull | 1 | 2003 | 63 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 121 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2003 | 453 | 0.010 |
Why?
|